Degradable Polymeric Carriers for Parenteral Controlled Drug Delivery

2011 ◽  
pp. 171-228 ◽  
Author(s):  
C. Wischke ◽  
S. P. Schwendeman
Keyword(s):  
Drug Delivery ◽  
Controlled Drug Delivery ◽  
Polymeric Carriers

New polymeric carriers for controlled drug delivery following inhalation or injection

Biomaterials ◽  
2002 ◽  
Vol 23 (22) ◽  
pp. 4425-4433 ◽  
Author(s):  
Jie Fu ◽  
Jennifer Fiegel ◽  
Eric Krauland ◽  
Justin Hanes
Keyword(s):  
Drug Delivery ◽  
Controlled Drug Delivery ◽  
Polymeric Carriers

scholarly journals Polymeric Carriers for Controlled Drug Delivery in Obesity Treatment

2019 ◽  
Vol 30 (12) ◽  
pp. 974-989 ◽  
Author(s):  
Di Huang ◽  
Meng Deng ◽  
Shihuan Kuang
Keyword(s):  
Drug Delivery ◽  
Controlled Drug Delivery ◽  
Obesity Treatment ◽  
Polymeric Carriers

Control of Immune Response by Endocrine Factors Malaria Vaccine Controlled Drug Delivery Enzyme-Immunoassay

1987 ◽  
Author(s):  
E. Debus ◽  
C. J. Grossmann ◽  
A. P. Hubbuch ◽  
H. N. Lanners ◽  
R. Linke ◽  
...  
Keyword(s):  
Drug Delivery ◽  
Immune Response ◽  
Enzyme Immunoassay ◽  
Malaria Vaccine ◽  
Controlled Drug Delivery ◽  
Endocrine Factors

Atherosclerosis and Nanomedicine Potential: Current Advances and Future Opportunities

2020 ◽  
Vol 27 (21) ◽  
pp. 3534-3554 ◽  
Author(s):  
Fan Jiang ◽  
Yunqi Zhu ◽  
Changyang Gong ◽  
Xin Wei
Keyword(s):  
Drug Delivery ◽  
Drug Delivery Systems ◽  
Controlled Drug Delivery ◽  
Vascular Wall ◽  
Arterial Disease ◽  
Diagnosis And Treatment ◽  
Antiinflammatory Therapy ◽  
Limited Efficacy ◽  
Conventional Drug ◽  
Diagnostic Modalities

Atherosclerosis is the leading inducement of cardiovascular diseases, which ranks the first cause of global deaths. It is an arterial disease associated with dyslipidemia and changes in the composition of the vascular wall. Besides invasive surgical strategy, the current conservative clinical treatment for atherosclerosis falls into two categories, lipid regulating-based therapy and antiinflammatory therapy. However, the existing strategies based on conventional drug delivery systems have shown limited efficacy against disease development and plenty of side effects. Nanomedicine has great potential in the development of targeted therapy, controlled drug delivery and release, the design of novel specific drugs and diagnostic modalities, and biocompatible scaffolds with multifunctional characteristics, which has led to an evolution in the diagnosis and treatment of atherosclerosis. This paper will focus on the latest nanomedicine strategies for atherosclerosis diagnosis and treatment as well as discussing the potential therapeutic targets during atherosclerosis progress, which could form the basis of development of novel nanoplatform against atherosclerosis.

Bioactive Hydrogel Scaffolds - Advances in Cartilage Regeneration Through Controlled Drug Delivery

2015 ◽  
Vol 21 (12) ◽  
pp. 1545-1555 ◽  
Author(s):  
Roberta Censi ◽  
Alessandra Dubbini ◽  
Pietro Matricardi
Keyword(s):  
Drug Delivery ◽  
Controlled Drug Delivery ◽  
Cartilage Regeneration ◽  
Hydrogel Scaffolds

Co-polymerized Gellan Gum: A Carrier for Controlled Drug Delivery

2016 ◽  
Vol 5 (3) ◽  
pp. 151-162
Author(s):  
Ranjeet Pareek ◽  
Shakuntla Verma ◽  
Viney Lather ◽  
Deepti Pandita
Keyword(s):  
Drug Delivery ◽  
Controlled Drug Delivery ◽  
Gellan Gum
Sign in / Sign up

Export Citation Format

Share Document